Monitor Capital Markets is currently offering the opportunity to invest in shares on the secondary market in four exciting companies - Boxbollen, Hernö Gin, Yabie and Sigrid Therapeutics.
Investing in private equity gives you access to innovative companies at an early stage of their development, while contributing to portfolio diversification. This type of investment provides exclusivity and access to markets and opportunities that are not available to the wider public.
Monitor Capital Markets is at your side to guide you through a safe, fast and smooth transaction.
About Hernö Gin
Discover Hernö Gin - Sweden's first dedicated gin distillery and the world's most award-winning gin! Founded in 2011 in the idyllic village of Dala, near Härnösand in the High Coast, Hernö Gin is created with great passion and craftsmanship. The distillery uses eight organic botanicals, including juniper berries from around the world, to create an exceptionally round and smooth gin with a distinct juniper character, fresh citrus notes and a unique floral complexity.
Read more about Hernö Gin here
About Yabie
Discover Yabie - the innovative Swedish start-up from Stockholm revolutionizing payment solutions since 2017! Yabie specializes in user-friendly, integrated payment systems that simplify sales for everything from small individual businesses to large chains like IKEA. With a client base ranging from large furniture stores to smaller local hair salons, Yabie delivers a versatile service that includes everything from checkout systems in smartphones (Yabie Go) to more comprehensive iPad-based solutions (Yabie Express)
Read more about Yabie here
Om About Sigrid Therapeutics
Sigrid Therapeutics, based in Stockholm, Sweden, is a leading health and technology company focused on preventing and treating lifestyle diseases such as diabetes and obesity. With its innovative medical device SiPore®, Sigrid offers a safe and natural solution to reduce blood sugar levels in people at risk of diabetes, pre-diabetics and people newly diagnosed with type 2 diabetes. SiPore® works by being consumed orally as a tasteless and odorless powder that, along with water, acts in the gastrointestinal tract to mechanically improve metabolic health.
Läs mer om Sigrid Therapeutics here
A selection of companies we have made transactions in →
We execute transactions in both small, innovative companies at an early stage, as well as in established, large and well-known ones. In total, it is about over 1 000 businesses, with a particular focus on around 70 of them. Through our network of investors, new companies and investment opportunities are continuously added.